Access cutting-edge severe hypertriglyceridemia treatment through this clinical trial at a research site in Wilmington. Study-provided care at no cost to qualified participants.
Access severe hypertriglyceridemia specialists in Wilmington at no cost
This study follows strict safety protocols and ethical guidelines
All study-related severe hypertriglyceridemia treatment provided free
This study will evaluate the efficacy and safety of plozasiran in approximately 140 adult participants with severe hypertriglyceridemia (SHTG) and history of at least two prior acute pancreatitis (AP) events not attributed to other etiologies, with at least one occurring within the last 12 months prior to screening. Eligible participants will be randomly assigned in a double-blind manner to either receive plozasiran 25 mg by subcutaneous (SC) injection every three months (Q3M) or matching placeb
Sponsor: Arrowhead Pharmaceuticals
Check if you qualify for this severe hypertriglyceridemia clinical trial in Wilmington, NC
If you're searching for severe hypertriglyceridemia treatment options in Wilmington, NC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Wilmington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced severe hypertriglyceridemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.